Cargando…
Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
Advanced cholangiocarcinoma continues to harbor a difficult prognosis and therapeutic options have been limited. During the course of a clinical trial of whole genomic sequencing seeking druggable targets, we examined six patients with advanced cholangiocarcinoma. Integrated genome-wide and whole tr...
Ejemplares similares
-
Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib
por: Bryce, Alan H., et al.
Publicado: (2016) -
Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers
por: Borad, Mitesh J., et al.
Publicado: (2016) -
Simultaneous Characterization of Somatic Events and HPV-18 Integration in a Metastatic Cervical Carcinoma Patient Using DNA and RNA Sequencing
por: Liang, Winnie S., et al.
Publicado: (2014) -
Paired Tumor and Normal Whole Genome Sequencing of Metastatic Olfactory Neuroblastoma
por: Weiss, Glen J., et al.
Publicado: (2012) -
Long insert whole genome sequencing for copy number variant and translocation detection
por: Liang, Winnie S., et al.
Publicado: (2014)